Global Fertility Network Acquires HealthPlus in Jeddah

Marking its second major transaction in Saudi Arabia this year, Saudi-Emirati Global Fertility Network (GFN), one of the fastest growing fertility and women’s health networks in the Middle East, has completed the acquisition of a majority controlling stake of HealthPlus Fertility Center in Jeddah.

The acquired facility will be rebranded under GFN’s Bnoon IVF brand, following the acquisition of Bnoon IVF Center in Riyadh earlier this year, GFN said in a statement.

These two strategic acquisitions represent an investment of more than $27 million and form the foundation of GFN’s plan to create the largest fertility network in Saudi Arabia and the wider GCC. Both centers, Bnoon and HealthPlus Fertility, were previously part of M42’s healthcare portfolio between 2022 and 2024.

With these transactions, GFN has doubled its capacity and now delivers over 5,000 IVF cycles annually, making it the largest stand-alone provider of assisted reproductive services in the Kingdom.

Moreover, a 3,800 sq. m. flagship facility is currently under construction in the northern part of Riyadh and is scheduled to open in December 2025, offering advanced fertility and reproductive genetics services, as part of a holistic women’s health offering.

Founder and CEO of GFN Majd Abu Zant said that the expansion in Saudi Arabia is part of GFN’s broader strategy to establish a regional platform of fertility and women’s health centers.

He said that under the Bnoon name, GFN brings together some of the leading Saudi IVF consultants with decades of clinical experience, supported by state-of-the-art IVF laboratories designed to deliver the highest standards in reproductive care.

Institutional Support

GFN’s growth is backed by significant institutional support. The group secured approximately $60 million in equity financing from a consortium of prominent institutional investors and family offices from Saudi Arabia and the UAE. Dubai Investments, a leading investment company listed on the Dubai Financial Market (DFM), acquired a 34.3% equity stake in GFN.

“We have identified a strong pipe-line of potential targets for acquisition across the region. New IVF facilities are also planned in Khobar, Abha, and additional cities across the Kingdom. With the support of our investment partners, we will expand our network while introducing cutting-edge technologies faster, enhancing clinical outcomes, and making fertility care more accessible across the region,” Abu Zant added.

Dr Abdulaziz Muhammad AlShahrani, a leading Saudi Reproductive Endocrinology & Infertility (IVF) Consultant, Founder and Group Medical Director of Bnoon, said that the demand for assisted reproductive technologies has been steadily rising in the Kingdom.

“We’re seeing a noticeable increase in couples seeking fertility treatment, driven by both primary and secondary infertility,” he said.

With growing awareness, more individuals are also considering fertility treatments to help balance their families and prevent genetic diseases. Addressing this growing demand requires more than clinical expertise alone, he said.

“Being part of a larger fertility network like GFN enables us to meet these needs more effectively, giving physicians the freedom to focus on care while benefiting from shared research, innovation, and access to advanced technologies. It’s the kind of ecosystem that drives excellence and expands what’s possible in reproductive medicine,” he added.